New study finds caldolor® safe and effective for opioid-sparing pain management in older adults

Analysis shows 23% reduction in morphine use with favorable safety profile in patients 60 years of age and older nashville, tenn. , may 27, 2025 /prnewswire/ -- cumberland pharmaceuticals inc. (nasdaq: cpix), a specialty pharmaceutical company, today announced the publication of its study investigating caldolor® (intravenous ibuprofen) in older patients.
CPIX Ratings Summary
CPIX Quant Ranking